The Valley Desk

NCT07783802 · Interventional trial

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Overall registry status Recruiting

Phase 2

Conditions Atherosclerosis, Cardiovascular Disease, Diabetes Mellitus, Type 2, Hypertension, Obesity, Renal Insufficiency, Chronic

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov